Q2 2023 · 13F-HR
Velan Capital Investment Management LPholdings as filed
Filed 2023-08-11 · accession 0001848809-23-000003
$107.7M
Reported value
31
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 471871103 | — | JASPER THERAPEUTICS INC | $14.8M | 13.8% | 11,219,036 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $10.1M | 9.34% | 2,726,051 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $8.4M | 7.79% | 100,000 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $7.6M | 7.02% | 746,087 | Common | SOLE |
| 74006W108 | — | PRAXIS PRECISION MEDICINES I | $6.0M | 5.54% | 5,185,000 | Common | SOLE |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $5.2M | 4.85% | 4,500,000 | Common | SOLE |
| 74880P104 | QIPT | QUIPT HOME MEDICAL CORP | $5.2M | 4.81% | 970,000 | Common | SOLE |
| 016259202 | — | ALIMERA SCIENCES INC | $4.8M | 4.50% | 1,659,654 | Common | SOLE |
| 68404V100 | — | OPTINOSE INC | $4.4M | 4.11% | 3,596,861 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $4.2M | 3.92% | 51,900 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $3.6M | 3.32% | 189,500 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $3.2M | 3.00% | 250,000 | Common | SOLE |
| 36338D108 | GRTX | GALERA THERAPEUTICS INC | $3.1M | 2.90% | 1,000,000 | Common | SOLE |
| 730541109 | — | POINT BIOPHARMA GLOBAL INC | $3.1M | 2.88% | 342,936 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $2.8M | 2.62% | 55,300 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $2.5M | 2.32% | 778,500 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $2.3M | 2.11% | 904,029 | Common | SOLE |
| 148806102 | CTLTEUR | CATALENT INC | $2.2M | 2.01% | 50,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $1.8M | 1.67% | 95,000 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $1.7M | 1.57% | 240,000 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $1.6M | 1.53% | 100,000 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $1.6M | 1.50% | 459,746 | Common | SOLE |
| 45114M109 | — | ICOSAVAX INC | $1.6M | 1.48% | 160,630 | Common | SOLE |
| 27966L108 | — | EDESA BIOTECH INC | $1.0M | 0.96% | 1,281,615 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $892,000 | 0.83% | 200,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $792,000 | 0.74% | 400,000 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $755,894 | 0.70% | 497,299 | Common | SOLE |
| 45720L107 | INBXUSD | INHIBRX INC | $649,000 | 0.60% | 25,000 | Common | SOLE |
| 009496100 | AIRS | AIRSCULPT TECHNOLOGIES INC | $646,500 | 0.60% | 75,000 | CALL | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $538,000 | 0.50% | 50,000 | Common | SOLE |
| 74880P104 | QIPT | QUIPT HOME MEDICAL CORP | $534,000 | 0.50% | 100,000 | CALL | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.